COVID-19 2022 update: transition of the pandemic to the endemic phase
- PMID: 35650595
- PMCID: PMC9156835
- DOI: 10.1186/s40246-022-00392-1
COVID-19 2022 update: transition of the pandemic to the endemic phase
Abstract
COVID-19, which is caused by the SARS-CoV-2, has ravaged the world for the past 2 years. Here, we review the current state of research into the disease with focus on its history, human genetics and genomics and the transition from the pandemic to the endemic phase. We are particularly concerned by the lack of solid information from the initial phases of the pandemic that highlighted the necessity for better preparation to face similar future threats. On the other hand, we are gratified by the progress into human genetic susceptibility investigations and we believe now is the time to explore the transition from the pandemic to the endemic phase. The latter will require worldwide vigilance and cooperation, especially in emerging countries. In the transition to the endemic phase, vaccination rates have lagged and developed countries should assist, as warranted, in bolstering vaccination rates worldwide. We also discuss the current status of vaccines and the outlook for COVID-19.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
COVID-19 Pandemic-to-Endemic Transition in Indonesia: What Does the Future Hold?Acta Med Indones. 2022 Apr;54(2):159-160. Acta Med Indones. 2022. PMID: 35818655
-
As Omicron Takes Hold and Other New Variants Arise, COVID-19 Testing Remains the Universally Agreed Tool to Effect Transition From Pandemic to Endemic State.Front Public Health. 2022 Apr 28;10:883066. doi: 10.3389/fpubh.2022.883066. eCollection 2022. Front Public Health. 2022. PMID: 35602143 Free PMC article.
-
Letter to the editor: Increase of influenza vaccination coverage rates during the COVID-19 pandemic and implications for the upcoming influenza season in northern hemisphere countries and Australia.Euro Surveill. 2021 Dec;26(50):2101143. doi: 10.2807/1560-7917.ES.2021.26.50.2101143. Euro Surveill. 2021. PMID: 34915972 Free PMC article. No abstract available.
-
[Consideration on implementation of co-administration of Seasonal Influenza and COVID-19 vaccines during pandemic in China].Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Feb 6;56(2):103-107. doi: 10.3760/cma.j.cn112150-20211203-01117. Zhonghua Yu Fang Yi Xue Za Zhi. 2022. PMID: 34954956 Review. Chinese.
-
Potential for elimination of SAR-CoV-2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination.J Med Virol. 2020 Nov;92(11):2453-2457. doi: 10.1002/jmv.26162. Epub 2020 Jun 29. J Med Virol. 2020. PMID: 32525587 Free PMC article. Review.
Cited by
-
Production of a Monoclonal Antibody to the Nucleocapsid Protein of SARS-CoV-2 and Its Application to ELISA-Based Detection Methods with Broad Specificity by Combined Use of Detector Antibodies.Viruses. 2022 Dec 21;15(1):28. doi: 10.3390/v15010028. Viruses. 2022. PMID: 36680068 Free PMC article.
-
Development of a Melting-Curve-Based Multiplex Real-Time PCR Assay for the Simultaneous Detection of Viruses Causing Respiratory Infection.Microorganisms. 2023 Nov 2;11(11):2692. doi: 10.3390/microorganisms11112692. Microorganisms. 2023. PMID: 38004704 Free PMC article.
-
Causes and Consequences of Coronavirus Spike Protein Variability.Viruses. 2024 Jan 25;16(2):177. doi: 10.3390/v16020177. Viruses. 2024. PMID: 38399953 Free PMC article. Review.
-
Trivalent SARS-CoV-2 S1 Subunit Protein Vaccination Induces Broad Humoral Responses in BALB/c Mice.Vaccines (Basel). 2023 Jan 31;11(2):314. doi: 10.3390/vaccines11020314. Vaccines (Basel). 2023. PMID: 36851191 Free PMC article.
-
The New Normal: Amotivation, Sense of Purpose, and Associated Factors Among College Students During the COVID-19 Pandemic.Psychol Rep. 2025 Aug;128(4):2336-2352. doi: 10.1177/00332941231181485. Epub 2023 Jun 2. Psychol Rep. 2025. PMID: 37265241 Free PMC article.
References
-
- National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. CDC COVID-19 Science Briefs. Atlanta (GA): Centers for Disease Control and Prevention (US); 2020–. Science Brief: Omicron (B.1.1.529) Variant. 2021 Dec 2. - PubMed
-
- Colona VL, Vasiliou V, Watt J, Novelli G, Reichardt JKV. Update on human genetic susceptibility to COVID-19: susceptibility to virus and response. Hum Genom. 2021;15(1):57. doi: 10.1186/s40246-021-00356-x.Erratum.In:HumGenomics.2021Sep18;15(1):59. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous